Press Releases

Sygnature Discovery Completes Major Enhancement of High-Throughput Chemistry Facilities Following £1 Million Investment

MIT Deploys Openwater’s Open-LIFU to Advance Neuroscience Research

MIT’s Lincoln Laboratory is first to receive the latest version of the device, with the goal to use low-intensity focused ultrasound to support its research exploring conscious perception.

Hoosier Cancer Research Network Report Reveals Key Trends Shaping Investigator-Initiated Oncology Trials

Hoosier Cancer Research Network has released a new report, “Investigator-Initiated Oncology Trials: Trends, Challenges, and Opportunities,” that captures the experience and perspectives of more than 130 researchers across its nationwide network. The findings highlight key trends shaping investigator-initiated oncology research and the operational, institutional, and funding challenges researchers face in today’s environment.

START and Advarra Unite to Deliver Unmatched Speed, Quality, and Predictability for Early-Phase Oncology Trials

START enhances its global leadership by integrating Advarra’s advanced regulatory and technology solutions, creating a seamlessly connected site network to accelerate trials and relieve pressure on the oncology drug development ecosystem.

Abzena Appoints Geoffrey M. Glass as Chief Executive Officer

Uniphar Rebrands On Demand Business to Uniphar Global Sourcing, Strengthening Global Pharmaceutical Offering

Sharp's Emissions Reduction Targets Validated by Science Based Targets initiative

Quotient Sciences Announces Formation of Scientific Advisory Board

Yourgene Health Launches LightBench Discover

Three-in-one system integrates large fragment analytics, DNA size selection and fluorometric quantification for long-read sequencing

Hongene Supports Clinical Advancement of siRNA DNV001 Using Proprietary Chemoenzymatic Ligation Platform

ClearNote Health Receives First In Vitro Diagnostic Approval for its Avantect® Pancreatic Cancer Test

ClearNote Health, a company focused on improving early detection for some of the deadliest cancers, today announced that it has received UK Conformity Assessed (UKCA) marking for its Avantect® Pancreatic Cancer Test. The UKCA mark, established as part of the United Kingdom’s independent product safety regulatory framework following its departure from the European Union, signifies compliance with UK medical device regulations and paves the way for commercial availability in the UK market.

ProPharma Appoints Marshall Florence, Ex-FDA Labeling Expert, as Vice President of Labeling to Advance Strategic Labeling & Promotional Review

New hire elevates strategic labeling solutions to support faster approval and smarter commercialization

Upperton Pharma Solutions Wins Business Expansion Award at the 2025 Pharmaceutical Technology Excellence Awards.

Nottingham, UK – [07.07.2025] – Upperton Pharma Solutions, a leading Nottingham-based pharmaceutical contract development and manufacturing organisation (CDMO), is delighted to announce its recognition as the winner of the Business Expansion award in the Integrated Manufacturing category at the 2025 Pharmaceutical Technology Excellence Awards.

CD Bioparticles Launches Advanced Bio-Targeted Small Molecules Conjugated Magnetic Nanoparticles for Targeted Cancer Therapy

CD Bioparticles announces its custom synthesis services of Bio-Targeted Small Molecules Conjugated Magnetic Nanoparticles (MNPs).

Axplora announces further €35M expansion at Farmabios to double footprint and fuel long-term growth

Creative Diagnostics Announces Advanced Microbial Genome Editing Services to Accelerate Bio-research

Creative Diagnostics launches Microbial Genome Editing services to support bioresearch.

Headlands Research Enters the Caribbean with Acquisition of CMRCenter

The deal pairs San Juan, Puerto Rico site’s deep community ties, top-tier enrollment, and 90% retention with Headlands’ network-wide infrastructure and resources to accelerate clinical research

PHARMASEAL and Viedoc Announce a Technical Integration Partnership

PHARMASEAL, provider of the Engility® Trial Management Platform consisting of a Clinical Trial Management System (CTMS) CTMS and Electronic Trial Master File (eTMF), has announced a Technology Integration Partnership with Viedoc, a global leader in Electronic Data Capture (EDC) and eClinical technologies. This collaboration integrates PHARMASEAL’s advanced CTMS platform with Viedoc’s cutting-edge EDC capabilities, including its flagship product Viedoc Clinic, to deliver a more integrated solution for life science companies managing clinical trials worldwide.

Gene by Gene Supports Landmark Pharmacogenomics Trial to Personalize Prescribing in NHS Scotland

Gene by Gene Supports Landmark Pharmacogenomics Trial to Personalize Prescribing in NHS Scotland

Takara Bio Europe signs distribution agreement with MACHEREY-NAGEL to expand access to high-quality bioanalysis products

Takara Bio Europe is pleased to announce it has entered into a distribution agreement with MACHEREY-NAGEL to expand access to high-quality bioanalysis products.